Pharmafile Logo
Pharmafocus logo
Advanced Search

Brazil

Showing 15 posts of 20 posts found.

Kintor’s COVID-19 treatment reduces mortality by 92%

March 12, 2021
Medical Communications Brazil, Brazil variant, COVID-19, Kintor, covid-19 treatment

Kintor Pharmaceutical’s Proxalutamide treatment has been proven to reduce risk of mortality from COVID-19 by 92%, in a clinical trial …

News
shutter

Amryt’s Lojuxta approved in Brazil to reduce cholesterol in homozygous familial hypercholesterolaemia patients

December 9, 2020
Research and Development, Sales and Marketing Amryt, Brazil, rare disease

Brazil’s National Health Surveillance Agency (ANVISA) has moved to authorise Amryt’s Lojuxta (lomitapide) in the country as a treatment for …

News
flu_vaccination_grippe_5115654021

Sinovac COVID-19 trial suspended in Brazil due to severe adverse event

November 10, 2020
Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus

Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …

News
brazil

Brazilian President Jair Bolsonaro tests positive for COVID-19, says he is taking hydroxychloroquine

July 8, 2020
Research and Development Brazil, COVID-19, President of Brazil

Jair Bolsonaro, the President of Brazil, has tested positive for COVID-19 and says he treating the virus with hydroxychloroquine. The …

News
novartis_window

Glenmark signs deal with Novartis over distribution in Brazil

June 24, 2019
Sales and Marketing Brazil, Glenmark, Latin America, Novartis, distribution, pharma

Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil. …

News

Measles outbreak threatens to decimate isolated Amazonian tribe in Venezuela and Brazil

October 25, 2018
Medical Communications Brazil, Venezuela, measles, tribe, vaccines, yanomami

An outbreak of measles threatens to decimate an isolated tribe in the Amazon, according to the non-profit organisation Survival International. …

News
aedes_aegypti_mosquito

Brazil declares end to Zika virus emergency

May 12, 2017
Medical Communications Brazil, Vaccine, Zika, Zika virus

Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop …

News

Advent reportedly backs out of bid for Pfizer’s Brazil plant

March 23, 2017
Sales and Marketing Brazil, Pfizer, generics

It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …

News
vaccination

Sanofi launches dengue immunisation program in Brazil

August 15, 2016
Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines

Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …

News
Brazil image

Brazil focus: not just another BRIC in the wall

April 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BRIC, Brazil, emerging markets, market access, rio

Population: 198.7 million (2012) Government: Federal presidential republic Leader: President Dilma Rousseff of the centre-left Workers’ Party Gross Domestic Product: …

Feature
Valeant image

Valeant shuts plant in Brazil, second to follow

January 8, 2013
Manufacturing and Production Brazil, Medicis, Valeant

Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the …

News

Brazil delays excipient GMP deadline

September 6, 2012
Manufacturing and Production ANVISA, Brazil, GMP

Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …

News

Capturing the Brazilian pharma opportunity

May 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …

Feature

Access to new cancer drugs limited in Brazil and Mexico

April 13, 2012
Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets

Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …

News
Merck image

Merck unveils Brazilian joint venture

February 17, 2012
Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets

Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …

News

Latest content

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023

Acesion Pharma raises €45m series B funding

September 26, 2023

CDC Advisory Committee recommends Pfizer’s RSV vaccine

September 25, 2023

FDA approves Eli Lilly and Boehringer Ingelheim’s Jardiance for chronic kidney disease treatment

September 25, 2023

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023